Keywords: عامل اختلال عروقی; Anti-angiogenic agent; Combretastatin A4-phosphate; Ovarian cancer; Vascular disrupting agent; Vascular-targeted therapy;
مقالات ISI عامل اختلال عروقی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل اختلال عروقی; BABB; benzyl benzoate:benzyl alcohol; BV; blood vessel; CMOS; complementary metal-oxide semiconductor; CT; computed tomography; FOV; field-of-view; GLCM; grey-level co-occurrence matrix; LN; lymph node; LV; lymph vessel; MZ; marginal zone; OPT; Optical Pr
Keywords: عامل اختلال عروقی; ECM; extracellular matrix; IFP; interstitial fluid pressure; EPR; enhanced permeation and retention; AI; angiogenesis inhibitors; VEGF; vascular endothelial growth factor; VDA; vascular disrupting agent; CEP; circulating endothelial progenitor; TACE; tran
Keywords: عامل اختلال عروقی; Nanomedicine; Active targeting; Cancer therapy; Vascular disrupting agent; Liposomes; Magnetic nanoworms
Keywords: عامل اختلال عروقی; Electrospun fiber; Vascular disrupting agent; Release modulation; Antitumor efficacy; Tumor metastasis
Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: AÂ VX2 Tumor Model Study
Keywords: عامل اختلال عروقی; ALT; alanine transaminase; AST; aspartate transaminase; HCC; hepatocellular carcinoma; VDA; vascular disrupting agent;
Computational design and synthesis of novel fluoro-analogs of combretastatins A-4 and A-1
Keywords: عامل اختلال عروقی; Combretastatin A-4 and A-1; Anticancer agent; Vascular disrupting agent; Fluoro-analog; Structure-based drug design; In silico screening; Structure-activity relationship;
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
Keywords: عامل اختلال عروقی; ANOVA; analysis of variance; BLI; bioluminescence imaging; CA4; combretastatin A-4; CA4P; combretastatin A-4 phosphate; DAPI; 4â²,6-diamidino-2-phenylindole; DMSO; dimethyl sulfoxide; DTT; dithiothreitol; FAK; focal adhesion kinase; FDA; Federal Drug Adm
A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
Keywords: عامل اختلال عروقی; Mesothelioma; Vascular Disrupting Agent; BNC105P; Clinical trial; Phase II; Biomarkers
Mechanisms of tumor resistance to small-molecule vascular disrupting agents: Treatment and rationale of combination therapy
Keywords: عامل اختلال عروقی; antiangiogenic therapy; tumor vasculature; vascular disrupting agent
Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs
Keywords: عامل اختلال عروقی; 3,5-Disubstituted 1,2,4-oxadiazole; Combretastatin A-4; Bioisosteres; Vascular disrupting agent; Tubulin; Boron-containing CA4 compound;
A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents
Keywords: عامل اختلال عروقی; Endothelial cell; Apoptosis; Caspase-3; Fluorescence resonance energy transfer; High-throughput screening; Vascular disrupting agent
Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer
Keywords: عامل اختلال عروقی; Angiogenesis; Non-small cell lung cancer; Tyrosine kinase inhibitor; Vascular disrupting agent; Second-line therapy
Synthesis and structure–activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents
Keywords: عامل اختلال عروقی; Anticancer drug; Benzophenone; Diketopiperazine; Microtubule depolymerizing activity; Vascular disrupting agent
Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A-1
Keywords: عامل اختلال عروقی; Combretastatin; Triazoles; Dihalogenation; Human umbilical vein endothelial cell; Ovarian cancer; Vascular disrupting agent;
Endostar enhances the antineoplastic effects of combretastatin A4 phosphate in an osteosarcoma xenograft
Keywords: عامل اختلال عروقی; Combretastatin A4 phosphate; Endostar; Vascular disrupting agent; Anti-angiogenesis agent; Osteosarcoma
Tubulin photoaffinity labeling study with a plinabulin chemical probe possessing a biotin tag at the oxazole
Keywords: عامل اختلال عروقی; Anti-cancer agent; Diketopiperazine; Phenylahistin; Tubulin; Vascular disrupting agent;
Investigation of protein induction in tumour vascular targeted strategies by MALDI MSI
Keywords: عامل اختلال عروقی; CA-4-P; combretastatin A-4-3-O-phosphate (CA-4-P/Zybrestatâ¢); MALDI MSI; Matrix-Assisted Laser Desorption/Ionisation-Mass Spectrometry Imaging; MALDI IMS-MSI; Matrix-Assisted Laser Desorption/Ionisation-Ion Mobility Separation-Mass Spectrometry Imaging;
Anti-microtubule ‘plinabulin’ chemical probe KPU-244-B3 labeled both α- and β-tubulin
Keywords: عامل اختلال عروقی; Anti-cancer agent; Diketopiperazine; Phenylahistin; Tubulin; Vascular disrupting agent
Delta-projection Imaging on Contrast-enhanced Ultrasound to Quantify Tumor Microvasculature and Perfusion
Keywords: عامل اختلال عروقی; Ultrasound contrast agents; power Doppler; angiogenesis; vascular disrupting agent; tumor perfusion;
The Disruption of Murine Tumor Neovasculature by Low-intensity Ultrasound-Comparison Between 1- and 3-MHz Sonication Frequencies
Keywords: عامل اختلال عروقی; Ultrasound antivascular effects; vascular disrupting agent; ultrasound microbubble contrast agent; low-intensity ultrasound therapy; cancer therapy;
Tumor Antivascular Effects of Radiotherapy Combined with Combretastatin A4 Phosphate in Human Non-Small-Cell Lung Cancer
Keywords: عامل اختلال عروقی; Radiotherapy; Vascular disrupting agent; Functional imaging; Computed tomography; Non-small-cell lung cancer;
Synthesis and structure–activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors
Keywords: عامل اختلال عروقی; Tubulin inhibitor; Tubulin polymerization; 1,2,4-Triazole; Vascular disrupting agent; Tumor vasculature; Antimitotic